Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Single-Ascending Dose (SAD) and Multiple- Ascending Dose (MAD) Study of CNM-Au8 in Healthy Male and Female Volunteers

NCT02755870 is registered in ClinicalTrials.gov with Clene Nanomedicine as lead sponsor.

NCT NCT02755870
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02755870 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Single-Ascending Dose (SAD) and Multiple- Ascending Dose (MAD) Study of CNM-Au8 in Healthy Male and Female Volunteers
Lead sponsor
Clene Nanomedicine
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2015
Completion date
October 31, 2016
Enrollment
86 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers - male and female